Fidelity Investments’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300M | Sell |
6,907,100
-586,526
| -8% | -$25.5M | 0.02% | 665 |
|
|
2025
Q1 | $280M | Sell |
7,493,626
-5,756
| -0.1% | -$215K | 0.02% | 671 |
|
|
2024
Q4 | $340M | Sell |
7,499,382
-3,100
| -0% | -$140K | 0.02% | 610 |
|
|
2024
Q3 | $441M | Sell |
7,502,482
-3,393
| -0% | -$199K | 0.03% | 522 |
|
|
2024
Q2 | $295M | Buy |
7,505,875
+761,973
| +11% | +$30M | 0.02% | 637 |
|
|
2024
Q1 | $448M | Buy |
6,743,902
+1,725,022
| +34% | +$115M | 0.03% | 493 |
|
|
2023
Q4 | $137M | Buy |
5,018,880
+579,082
| +13% | +$15.8M | 0.01% | 902 |
|
|
2023
Q3 | $89.6M | Buy |
+4,439,798
| New | +$89.6M | 0.01% | 1025 |
|